Decreased expression levels of the MYO6 protein in <i>ksv</i> mice. by Yuta Seki (4385833)

“…Expression of MYO6 is completely ablated in the hair cells of <i>Myo6</i>^-/- mice (C). Scale bar = 5 μm. D and E. Western blot analysis of homogenates prepared from the inner ears of +/+, +/<i>ksv</i> and <i>ksv/ksv</i> mice at P30 detected with anti-MYO6 (N-ter, D) and MYO6 (C-ter, E) antibodies (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0183477#pone.0183477.s007" target="_blank">S2 Table</a>). …”

Repeat peptide stimulation decreases <i>in vivo</i> CTL expansion capacity. by Manzhi Zhao (9023381)

V2 vasopressin receptor abundance. by Sophie Constantin Lütken (689916)

Subjects:

Repeat peptide stimulated CD8+ T cells have decreased cytotoxic function. by Manzhi Zhao (9023381)

A genetic variant in human FIRE is associated with a decreased interferon response in myeloid cells. by Anaïs Assouvie (9600529)

Osteocyte-rich cell fractions isolated from <i>Hyp</i> femurs show increased mRNA expression of PPi-regulating genes and decreased mRNA expression of <i>Tnap</i> ex vivo. by Sathish K. Murali (2585914)

Fullerol treatment decreased the accumulation of leukocytes in the liver at 20 days after transplant. by Priscila T. T. Bernardes (559311)

WNT3 decreases GCP proliferation by inhibiting SHH dependent gene transcription. by Sandrine L. Anne (489755)

“…<p>(<i>A</i>) WNT3 decreased proliferation of GCPs by 40.3± 5.0% of the control (Con) (n=3) as measured by [³H]-Thymidine incorporation assay. …”

Variability is correlated with increasing repeat length, increasing purity, and decreasing unit size. by John W. Fondon III (145820)

RNF5 loss decreases ERK and Akt activation, CDK1 and Smo expression and KSHV lytic replication in PEL cells. by Xiaojuan Li (351842)

Cigarette smoke exposure decreases whole body weight and skeletal muscle mass. by Marc-André Caron (422349)

BJ-3105 decreases the percentage of Th1 and Th17 cells differentiation. by Maheshwor Timilshina (3663667)

Cisplatin treatment triggered a decrease in PTEN levels and subsequent phosphorylation of key proteins in the PTEN/Akt/FOXO3 pathway. by Eun Mi Chang (837213)

25OHD₃ increases expression of TRPV6 and Calbindin-D9k in duodenum of CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

25OHD₃ does not induce vascular calcification in CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

25OHD₃ restores calcium and PTH levels in CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

The effect of 25OHD3 on the expression of renal PMCA1b and NCX1 in CYP27B1^+/+ and CYP27B1^-/- mice. by Noelia Torremadé (3687523)

25OHD₃ increases expression of CalbindinD-28K in the kidneys of CYP27B1^-/- mice with CKD. by Noelia Torremadé (3687523)

Loss of Vps34 is associated with decreased eTreg survival but intact activation. by Erienne G. Norton (9612079)

DXM administration increases time spent in the wake state and decreases that in NREM sleep. by Tomonobu Kato (17684578)